Changing outcomes in percutaneous coronary interventions: A study of 34,752 procedures in Northern New England, 1990 to 1997

Journal of the American College of Cardiology

Volumn 34, Issue 3, 1999, Pages 674-680

  McGrath, Paul D ^a   Malenka, David J ^b   Wennberg, David E ^a,b   Shubrooks Jr , Samuel J ^d   Bradley, William A ^c   Robb, John F ^b   Kellett Jr , Mirle A ^a   Ryan Jr , Thomas J ^a   Hearne, Michael J ^e   Hettleman, Bruce ^b   O'Meara, John R ^a   VerLee, Peter ^f   Watkins, Matthew W ^g   Piper, Winthrop D ^b   O'Connor, Gerald T ^b  

^a MAINE MEDICAL CENTER   (United States)

^b Section of Cardiology   (United States)

^c CATHOLIC MEDICAL CENTER   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e Elliot Hospital   (United States)

^f EASTERN MAINE MEDICAL CENTER   (United States)

^g FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHERECTOMY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; DATA COLLECTION; EMERGENCIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW ENGLAND; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES;

EID: 0032858882     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00257-0     Document Type: Article

References (28)

1. Gruentzig A.R., Turina M.I., Schneider J.A. Experimental percutaneous dilatation of coronary artery stenosis. (abstr). Circulation. 54:(Suppl II):1976;81.
2. Topol E.J., Serruys P.W. Frontiers in interventional cardiology. Circulation. 98:1998;1802-1820.
3. Jollis J.G., Peterson E.D., Nelson C.L., et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. Circulation. 95:1997;2485-2491.
4. McGrath P.D., Wennberg D.E., Malenka D.J., et al. Operator volume and outcomes in 12,998 percutaneous coronary interventions. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 31:1998;570-576.
5. Hearn J.A., King S.B., Douglas-JS J., et al. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design. Circulation. 88:1993;2086-2096.
6. Schomig A., Neumann F.J., Kastrati A., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 334:1996;1084-1089.
7. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med. 330:1994;956-961.
8. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med. 336:1997;1689-1696.
9. Bredlau C.E., Roubin G.S., Leimgruber P.P., et al. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation. 72:1985;1044-1052.
10. Summary of Minutes of the Meeting of the Circulatory System Devices Panel, Food and Drug Administration, Bethesda, MD, May 2-3, 1994. Bethesda, MD: Food and Drug Administration, 1994.
11. Serruys P.W., de-Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 331:1994;489-495.
12. Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 331:1994;496-501.
13. Detre K., Holubkov R., Kelsey S., et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. N Engl J Med. 318:1988;265-270.
14. Jones R.H., Kesler K., Phillips H.R., et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 111:1996;1013-1025.
15. King S.B., Yeh W., Holubkov R., et al. Balloon angioplasty versus new device intervention clinical outcomes. A comparison of the NHLBI PTCA and NACI registries . J Am Coll Cardiol. 31:1998;558-566.
16. Malenka D.J. Indications, practice, and procedural outcomes of percutaneous transluminal coronary angioplasty in northern New England in the early 1990s. The Northern New England Cardiovascular Disease Study Group. Am J Cardiol. 78:1996;260-265.
17. O'Connor G.T., Plume S.K., Olmstead E.M., et al. A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. JAMA. 275:1996;841-846.
18. Ryan T.J., Faxon D.P., Gunnar R.M., et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 78:1988;486-502.
19. Ryan T.J., Bauman W.B., Kennedy J.W., et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 88:1993;2987-3007.
20. Ellis S.G., Omoigui N., Bittl J.A., et al. Analysis and comparison of operator-specific outcomes in interventional cardiology. From a multicenter database of 4860 quality-controlled procedures. Circulation. 93:1996;431-439.
21. Hannan E.L., Arani D.T., Johnson L.W., et al. Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes. JAMA. 268:1992;3092-3097.
22. Fleiss J. Statistical Methods for Rates and Proportions. 1981;John Wiley, New York.
23. Kleinbaum D.G., Kupper L.L., Morgenstern H. Epidemiologic Research Principles and Quantitative Methods . 1982;Wadsworth, Inc, Belmont, CA.
24. Kahn H.A., Sempas C.T. Statistical Methods in Epidemiology. 1989;Oxford University Press, New York.
25. Lincoff A.M., Topol E.J., Chapekis A.T., et al. Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty a matched case-control study . J Am Coll Cardiol. 21:1993;866-875.
26. Roubin G.S., Cannon A.D., Agrawal S.K., et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation. 85:1992;916-927.
27. Hannan E.L., Racz M., Ryan T.J., et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA. 277:1997;892-898.
28. Pilote L., Califf R.M., Sapp S., et al. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. N Engl J Med. 333:1995;565-572.